All News
@kristenyoung @rheum_covid project on impact of COVID-19 on our trainees. Love the graphics by @EBRheum . Negatives are physical health, stress levels, and burnout all ⬆️ . Positives? Trainees did feel supported by programmes. Abstr#0485 #ACR21 @RheumNow https://t.co/kXQ1AUNrgb
Richard Conway RichardPAConway ( View Tweet)
Interested in the intersection of the arts/humanities and becoming a better version of yourself? If so join us for the 1st such event tomorrow AM at #ACR21 @AWIRGROUP @CleClinicLCM @GoldFdtn #empathy @CCalabreseDO @CleClinicMD @bschillace @psufka @RheumNow #humanities https://t.co/xwDF2ZLrXk
Leonard Calabrese LCalabreseDO ( View Tweet)
Leverenz et al.
@RheumMadness an online community of inquiry leading to a collaborative learning experience for fellows from 14 fellowship programs in the US
⭐️Full participants strongly agreed it fostered meaningful cognitive, social, and teaching
Abst# 0484 #ACR21 @RheumNow
swethaann23 swethaann23 ( View Tweet)
HCP #burnout coping strategies listed during 6S228 Let’s talk about mental health #ACR21 - writing, yoga, exercise, gardening, drawing& other creativity. I practice gratitude 🙏🏻 @RheumNow Burnout is real and magnified by #COVID19 pressures https://t.co/PUklM2Ci6e
Janet Pope Janetbirdope ( View Tweet)
Are we getting closer to personalised medicine in #psoriaticarthritis Predicting progressors vs non-progressors using proteomics identified 103 candidate biomarker peptides that will discriminate the two groups @RheumNow #ACR21 #ACRBest Abst#0449 https://t.co/obDXTz3i5N
Dr. Antoni Chan synovialjoints ( View Tweet)
Excellent scientific session on #SpA at #ACR21 right now- especially like this clear diagram of pathophysiology and useful summary slide from Dr Nigil Haroon on differences between #axSpA and axial #PsA
@RheumNow https://t.co/F7Ns7e9HQI
Mrinalini Dey DrMiniDey ( View Tweet)
“The differences and similarities between axial disease in psoriatic arthritis vs axial spondyloarthritis is just at the cusp of discovery” Nigil Haroon at session 6S403 @RheumNow #ACR21
Dr. Antoni Chan synovialjoints ( View Tweet)
My exclusive interview w/the GRA Powerhouse!
What are they studying next?
👉impact of COVID policies on Rheum pts
👉pt's perception w/COVID vaccines
👉COVID risk calculator
👉long haulers w/ rheum dz
👉breakthrough infections
@rheumnow https://t.co/dVLayNchHT @rheum_covid https://t.co/B1KIjxYt15
TheDaoIndex KDAO2011 ( View Tweet)
In this video, @rheumnow faculty recapped pre-ACR events, opening day lecture with @DrDavidKarp @DoctorYasmin year in review.
#ACR21 @uptoTate @RHEUMarampa
https://t.co/CO1uIyj1Z0 via @YouTube
TheDaoIndex KDAO2011 ( View Tweet)
Tyk2/Jak1 inhibitor brepocitinib in PsA. Looks good. Works for skin, joints, enthesitis, dactylitis, and PROs. No unexpected safety signals. Abstr#0488 #ACR21 @RheumNow https://t.co/MIOLw8BABN
Richard Conway RichardPAConway ( View Tweet)
Prolonging the Controversy of Hydroxychloroquine
Dr. Kathryn Dao (@KDAO2011 ) shares several abstracts from #ACR21 that addressed the topic of HCQ and cardiovascular safety.
https://t.co/J6sVzYJkUZ https://t.co/dBZmtwQ927
Links:
Dr. John Cush RheumNow ( View Tweet)
My first video for #ACR21 for @RheumNow, discussing #SickLeave, #WorkParticipation and #WorkDisability in patients with #SpA, with a focus on abstracts 0380 and 0381 by @ElenaNikiUK
#axspa #spondyloarthritis #arthritis #qualityoflife
Watch it here👇🏼
https://t.co/MEQ4wkFxrx
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR21 #Abstr0252 Let's examine our patients than relying on tests. In sJIA pts presenting with fever, clinical features (fever pattern, rash and MSK symptoms) distinguished inflammation vs infection but not CRP, ferritin and procalcitonin @RheumNow https://t.co/s61WGBVK73 https://t.co/qhN95GdwgJ
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
A key reason I'm looking forward to in-person conferences again, is so I don't have to perform the mental gymnastics and stress of ensuring I make all the sessions and meetings on time! 😂
⏰UK colleagues- time difference for #ACR21 will be +5️hours from tomorrow!
@RheumNow https://t.co/wl7ij3vyOU
Mrinalini Dey DrMiniDey ( View Tweet)
Top Influencers of #acr21: @ACRheum @rheum_cat @RheumNow @CreakyJoints @DoctorYasmin @KDAO2011 More 📊 https://t.co/vyMAwjKbqC
Symplur Hashtags healthhashtags ( View Tweet)
There is a strong association with pre-ICI autoantibody positivity and any-type irAE development as well as high specificity of RF and CCP for ICI-arthritis. Prospective evaluation of RF/CCP pre-treatment may be useful @RheumNow #ACR21 Abst#0440 https://t.co/P7L7pL1iuV
Dr. Antoni Chan synovialjoints ( View Tweet)
Excellent debate in #Lupus nephritis 6S214 with Wofsy, Isenberg & Costenbader. Q’s. What to do about Class V renal, many class III, IV LNdon’t go into sustained remission, cases of new onset LN in pts with #Belimumab ?more/less than expected, which drug to use @RheumNow #ACR21 https://t.co/tWbw79dE7d
Janet Pope Janetbirdope ( View Tweet)
Torgutalp et al.
⭐️Included Early axSpA - 166 nr-axSpA (symptom duration ≤5 y) and 135 with r-axSpA (symptom duration ≤10 y) from German Cohort
⭐️Assessed TNFI use over 2 years and has shown🔽 in radiographic sacroiliitis progression.
Abst#0451 #ACR21 @RheumNow #ACRBest https://t.co/xP0wMLSyGw
swethaann23 swethaann23 ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
IL-22 as a potential biomarker of AxSpA from non-inflammatory mimickers?
⬆️IL-22 in AxSpA vs. controls
⭐️IL-22 did not correlate w/ mSASSS, BASADI, ASDAS, CRP
Abs#385
#ACR21
@RheumNow https://t.co/hNtStAluJH
Robert B Chao, MD doctorRBC ( View Tweet)